Patient Baseline & Medication
Clinical consensus emphasizes high protein intake during GLP-1 therapy to prevent sarcopenic lean mass loss.
Total Weight to Lose
50 lbs
21.7% of Body Weight
24-Week Target
193 lbs
Estimated Benchmark
Daily Protein Target
216 g
Muscle Defense Floor
Daily Water Target
115 oz
3.4 Liters / Day
Physician Supervision & Titration Protocol
GLP-1 receptor agonists (Semaglutide) and dual GIP/GLP-1 co-agonists (Tirzepatide) require physician prescription and ongoing laboratory monitoring. Titration schedules mandate minimum 4-week step-up increments to mitigate gastrointestinal side effects.
- Baseline comprehensive metabolic panel & lipid profile
- High-protein intake (1.6–2.2g/kg) to protect fat-free lean mass
- Resistance training to prevent sarcopenic lean tissue depletion
ToolsVault Partner Directory:
Institutional Perks & Deals
Ergonomics, Power & Professional Tools
Clinical Trial Milestone Projections
SURMOUNT-1 Data
| Milestone | Standard Titration Dose | Projected Weight | Cumulative Loss |
|---|